We explored the expression difference of CD44 among pan-glioma transcriptome subtype (Figure 4A), pan-glioma DNA methylation subtype (Figure 4C), and supervised pan-glioma subtype (Figure 4E). This evidence concerns the gene CD44 and central nervous system cancer.